Oral Dextrose Gel for Management of Neonates at Risk for Hypoglycemia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20190805003

Enrollment

600

Registered

2019-08-05

Start date

2019-08-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infants at risk for hypoglycemia Hypoglycemia Infants

Interventions

&#45

Dry the inside of the buccal mucosa with gauze &#45

Squeeze gel onto gloved finger &#45

Massage gel 0.5 ml/kg of 40% Dextrose gel into the both sides of buccal mucosa ,Apply as intervention arm 1 with arboxymethyl cellulose gel

Active Comparator Drug,Placebo Comparator No treatment

Oral dextros gel,Placebo gel

Eligibility

Sex/Gender

All

Age

30 Years to 48 Hours

Inclusion criteria

Inclusion criteria: All asymptomatic infants at risk for hypoglycemia include: Late preterm infants (GA 34-366/7 week) Infants of diabetic mother Small for gestational age (BW 90th percentile) Low birth weight (BW 4000 g)

Exclusion criteria

Exclusion criteria: -Birth weight less than 1800 g -Previous treatment for hypoglycemia by either oral feed or intravenous fluid -Congenital abnormality -Admitted to NICU

Design outcomes

Primary

Measure	Time frame
Admission rate due to treatment failure within 0.5 hour after intrvention blood sugar	—

Secondary

Measure	Time frame
Length of hospital stay Length of hospital stay Length of hospital stay	—

Countries

Thailand

Contacts

Public ContactPracha Nuntnarumit

Ramathibodi hospital

pracha.nun@mahidol.ac.th66819475906

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026